Krans M - Search Results

1

Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

Wisman GB, Hollema H, de Jong S, ter Schegget J, Tjong-A-Hung SP, Ruiters MH, Krans M, de Vries EG, van der Zee AG. Wisman GB, et al. Among authors: krans m. J Clin Oncol. 1998 Jun;16(6):2238-45. doi: 10.1200/JCO.1998.16.6.2238. J Clin Oncol. 1998. PMID: 9626226 Clinical Trial.

2

Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.

Wisman GB, Hollema H, Helder MN, Knol AJ, Van der Meer GT, Krans M, De Jong S, De Vries EG, Van der Zee AG. Wisman GB, et al. Among authors: krans m. Int J Oncol. 2003 Nov;23(5):1451-9. doi: 10.3892/ijo.23.5.1451. Int J Oncol. 2003. PMID: 14532990

3

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

van der Zee AG, Hollema H, Suurmeijer AJ, Krans M, Sluiter WJ, Willemse PH, Aalders JG, de Vries EG. van der Zee AG, et al. Among authors: krans m. J Clin Oncol. 1995 Jan;13(1):70-8. doi: 10.1200/JCO.1995.13.1.70. J Clin Oncol. 1995. PMID: 7799045

4

Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.

Wisman GB, Knol AJ, Helder MN, Krans M, de Vries EG, Hollema H, de Jong S, van der Zee AG. Wisman GB, et al. Among authors: krans m. Int J Cancer. 2001 Mar 1;91(5):658-64. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1099>3.0.co;2-7. Int J Cancer. 2001. PMID: 11267977

5

Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.

van der Zee AG, de Cuyper EM, Limburg PC, de Bruijn HW, Hollema H, Bijzet J, Krans M, de Vries EG. van der Zee AG, et al. Among authors: krans m. Cancer. 1995 Feb 15;75(4):1004-9. doi: 10.1002/1097-0142(19950215)75:4<1004::aid-cncr2820750416>3.0.co;2-g. Cancer. 1995. PMID: 7842401

6

Rising serum values of beta-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas.

de Bruijn HW, ten Hoor KA, Krans M, van der Zee AG. de Bruijn HW, et al. Among authors: krans m. Br J Cancer. 1997;75(8):1217-8. doi: 10.1038/bjc.1997.208. Br J Cancer. 1997. PMID: 9099973 Free PMC article.

7

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG. Duk JM, et al. Among authors: krans m. Gynecol Oncol. 1990 Nov;39(2):186-94. doi: 10.1016/0090-8258(90)90430-s. Gynecol Oncol. 1990. PMID: 2227594

8

Squamous cell carcinoma of the vagina: a report of 32 cases.

Bouma J, Burger MP, Krans M, Hollema H, Pras E. Bouma J, et al. Among authors: krans m. Int J Gynecol Cancer. 1994 Nov;4(6):389-394. doi: 10.1046/j.1525-1438.1994.04060389.x. Int J Gynecol Cancer. 1994. PMID: 11578439

9

The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.

Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. Burger MP, et al. Among authors: krans m. Gynecol Oncol. 1995 Jun;57(3):327-34. doi: 10.1006/gyno.1995.1151. Gynecol Oncol. 1995. PMID: 7774836

10

Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.

van der Sijde R, de Bruijn HW, Krans M, Bouma J, Aalders JG. van der Sijde R, et al. Among authors: krans m. Gynecol Oncol. 1989 Nov;35(2):227-32. doi: 10.1016/0090-8258(89)90049-8. Gynecol Oncol. 1989. PMID: 2807015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters